Related by context. Frequent words. (Click for all words.) 73 GlaxoSmithKline Bristol Myers 67 Initiates Phase II 65 Takeda Kyowa Hakko Kirin 65 AstraZeneca Bristol Myers 64 Company Nasdaq PRGO 64 Files Shelf Registration Statement 63 Inc Therapeutic Competitors 63 Presents Positive 63 Idec Roche 63 Completes Enrollment 63 Vytorin combines 63 PROFILE CO 62 Director Exercises Options 61 FDA Clears 61 CEO Exercises Options 61 Bayer HealthCare subsidiary 60 PRODUCT SOURCE 60 FDA Accepts 60 Voluntarily Recalls 60 Bearish Pressure Building 60 Calls Purchased 59 Zacks Analyst Interview 59 Holds Annual Meeting 59 Completes Tender Offer 59 Signs Licensing Agreement 59 Earnings Scorecard 59 Announces Organizational Changes 59 www.syntapharma.com 59 Announce Collaboration 59 Copegus R 59 Finalizes Acquisition 59 Develop Novel 59 Movers Roundup 58 Nasdaq AMGN 58 Corp. Nasdaq GENZ 58 Mad Money merchandise 58 Approaching Resistance 58 F#Q# Qtr End 58 Q2 Loss Narrows 58 Guides Below 58 Connetics Corporation 58 Maintains Buy Rating 58 Report companiesandmarkets.com adds 58 Exploit collaboration 58 Announces Webcast 57 Co Morning Commentary 57 Conference Call TRANSCRIPT 57 Analysts Upgrades Downgrades 57 www.aidshealth.org 57 Announces Additions 57 Directors Declares Quarterly 57 Directors Elects 57 Lowers Guidance 57 Bearish Moving Average 57 Zacks Earnings Preview 57 Declares Regular Quarterly 57 Options Brief 57 Trend Continues Down 57 Webcast Annual Meeting 57 Generic Version 57 www.gsk.com 57 Q3 Loss Narrows 57 Drug Candidate 56 Stock Upgraded 56 Options Trader Alert 56 RELEASES ITS QUARTERLY NUMBERS 56 Inc. FY# Q3 56 available philippines uk 56 Q1 Loss Narrows 56 Winning Streak Continues 56 Downtrend Spotted 56 Declares Regular Quarterly Dividend 56 Small Molecule 56 PHARMACEUTICALS 56 Q1 Loss Widens 56 Unveils Innovative 56 SRS Labs supports 56 Q2 Loss Widens 56 Q1 Profit Surges 56 Author Affiliations 56 Introduces Innovative 56 Announces Appearance 56 Inc. Nasdaq IMGN 56 Inc. F#Q# Qtr 56 Bayhill Therapeutics 56 Exclusive Registry 56 Releases Enhanced 56 Announces Presentation 56 Renews Agreement 56 Trend Continues Lower 55 Stock Downgraded 55 Q3 Profit Surges 55 FDA Warns 55 Trend Continues Higher 55 Guides FY# Quick Facts 55 Declares Fourth Quarter 55 Announces Sponsorship 55 Trend Continues Up 55 Q4 Loss Narrows 55 R sorafenib tablets 55 Analysts Begin Coverage